<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36514781</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2688-2663</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>MedComm</Title><ISOAbbreviation>MedComm (2020)</ISOAbbreviation></Journal><ArticleTitle>Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions.</ArticleTitle><Pagination><StartPage>e196</StartPage><MedlinePgn>e196</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e196</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/mco2.196</ELocationID><Abstract><AbstractText>COVID-19 caused by SARS-CoV-2 infection affects humans not only during the acute phase of the infection, but also several weeks to 2 years after the recovery. SARS-CoV-2 infects a variety of cells in the human body, including lung cells, intestinal cells, vascular endothelial cells, olfactory epithelial cells, etc. The damages caused by the infections of these cells and enduring immune response are the basis of long COVID. Notably, the changes in gene expression caused by viral infection can also indirectly contribute to long COVID. We summarized the occurrences of both common and uncommon long COVID, including damages to lung and respiratory system, olfactory and taste deficiency, damages to myocardial, renal, muscle, and enduring inflammation. Moreover, we provided potential treatments for long COVID symptoms manifested in different organs and systems, which were based on the pathogenesis and the associations between symptoms in different organs. Importantly, we compared the differences in symptoms and frequency of long COVID caused by breakthrough infection after vaccination and infection with different variants of concern, in order to provide a comprehensive understanding of the characteristics of long COVID and propose improvement for tackling COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. MedComm published by Sichuan International Medical Exchange &amp; Promotion Association (SCIMEA) and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>He</LastName><ForeName>Shi-Ting</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>College of Life Science and Technology Beijing University of Chemical Technology Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Kexin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>College of Life Science and Technology Beijing University of Chemical Technology Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Zixuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>College of Life Science and Technology Beijing University of Chemical Technology Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Mengjie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Life Science and Technology Beijing University of Chemical Technology Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Ruolan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>College of Life Science and Technology Beijing University of Chemical Technology Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>College of Life Science and Technology Beijing University of Chemical Technology Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Life Science and Technology Beijing University of Chemical Technology Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qirui</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>College of Life Science and Technology Beijing University of Chemical Technology Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Huahao</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-5007-2158</Identifier><AffiliationInfo><Affiliation>College of Life Science and Technology Beijing University of Chemical Technology Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Yigang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Life Science and Technology Beijing University of Chemical Technology Beijing China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>MedComm (2020)</MedlineTA><NlmUniqueID>101769925</NlmUniqueID><ISSNLinking>2688-2663</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2</Keyword><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2 variants</Keyword><Keyword MajorTopicYN="N">breakthrough infection</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>2</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36514781</ArticleId><ArticleId IdType="pmc">PMC9732402</ArticleId><ArticleId IdType="doi">10.1002/mco2.196</ArticleId><ArticleId IdType="pii">MCO2196</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Willi S, L&#xfc;thold R, Hunt A, et&#xa0;al. COVID&#x2010;19 sequelae in adults aged less than 50 years: a systematic review. Travel Med Infect Dis. 2021;40:101995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898978</ArticleId><ArticleId IdType="pubmed">33631340</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu A, Hong B, Lou F, et&#xa0;al. Sub&#x2010;lineages of the SARS&#x2010;CoV&#x2010;2 omicron variants: characteristics and prevention. MedComm (2020). 2022;3(3):e172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9380698</ArticleId><ArticleId IdType="pubmed">35992968</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Lou F, Fan H. SARS&#x2010;CoV&#x2010;2 variant omicron: currently the most complete &#x201c;escapee&#x201d; from neutralization by antibodies and vaccines. Signal Transduct Target Ther. 2022;7(1):28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8795721</ArticleId><ArticleId IdType="pubmed">35091532</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalski JE, Kurche JS, Schwartz DA. From ARDS to pulmonary fibrosis: the next phase of the COVID&#x2010;19 pandemic. Transl Res. 2022;241:13&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8452088</ArticleId><ArticleId IdType="pubmed">34547499</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et&#xa0;al. Cardiopulmonary recovery after COVID&#x2010;19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4):2003481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J, Ben&#xed;tez ID, Carmona P, et&#xa0;al. Pulmonary function and radiologic features in survivors of critical COVID&#x2010;19: a 3&#x2010;month prospective cohort. Chest. 2021;160(1):187&#x2010;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930807</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AS, Wong AW, Hague CJ, et&#xa0;al. A prospective study of 12&#x2010;week respiratory outcomes in COVID&#x2010;19&#x2010;related hospitalisations. Thorax. 2021;76(4):402&#x2010;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID&#x2010;19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Meije Y, Duarte&#x2010;Borges A, Sanz X, et&#xa0;al. Long&#x2010;term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study. Clin Microbiol Infect. 2021;27(8):1151&#x2010;1157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8062910</ArticleId><ArticleId IdType="pubmed">33901667</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero&#x2010;Duarte &#xc1;, Rivera&#x2010;Izquierdo M, Guerrero&#x2010;Fern&#xe1;ndez de Alba I, et&#xa0;al. Sequelae, persistent symptomatology and outcomes after COVID&#x2010;19 hospitalization: the ANCOHVID multicentre 6&#x2010;month follow&#x2010;up study. BMC Med. 2021;19(1):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, et&#xa0;al. Health outcomes in people 2 years after surviving hospitalisation with COVID&#x2010;19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863&#x2010;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et&#xa0;al. Long COVID in adults discharged from UK hospitals after COVID&#x2010;19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8:100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et&#xa0;al. Short&#x2010;term and long&#x2010;term rates of postacute sequelae of SARS&#x2010;CoV&#x2010;2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Fan Y, Alwalid O, et&#xa0;al. Fibrotic interstitial lung abnormalities at 1&#x2010;year follow&#x2010;up CT after severe COVID&#x2010;19. Radiology. 2021;301(3):E438&#x2010;E440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8335811</ArticleId><ArticleId IdType="pubmed">34313470</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortini A, Torrigiani A, Sbaragli S, et&#xa0;al. COVID&#x2010;19: persistence of symptoms and lung alterations after 3&#x2013;6 months from hospital discharge. Infection. 2021;49(5):1007&#x2010;1015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8179958</ArticleId><ArticleId IdType="pubmed">34091869</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Yang C, An X, et&#xa0;al. Follow&#x2010;up study on COVID&#x2010;19 survivors one year after discharge from hospital. Int J Infect Dis. 2021;112:173&#x2010;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8434916</ArticleId><ArticleId IdType="pubmed">34520845</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Gao Y, Chen M, et&#xa0;al. Impaired pulmonary function in discharged patients with COVID&#x2010;19: more work ahead. Eur Respir J. 2020;56(1):2002194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315814</ArticleId><ArticleId IdType="pubmed">32586883</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID&#x2010;19: from an acute to chronic disease? Potential long&#x2010;term health consequences. Crit Rev Clin Lab Sci. 2021;58(5):297&#x2010;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Tonkin J, Devaraj A, et&#xa0;al. CT lung abnormalities after COVID&#x2010;19 at 3 months and 1 year after hospital discharge. Radiology. 2022;303(2):444&#x2010;454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515207</ArticleId><ArticleId IdType="pubmed">34609195</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Ding C, Yu L, et&#xa0;al. One&#x2010;year follow&#x2010;up of chest CT findings in patients after SARS&#x2010;CoV&#x2010;2 infection. BMC Med. 2021;19(1):191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8349604</ArticleId><ArticleId IdType="pubmed">34365975</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchino M, Lieto R, Romano F, et&#xa0;al. Chest CT&#x2010;based assessment of 1&#x2010;year outcomes after moderate COVID&#x2010;19 pneumonia. Radiology. 2022;305(2):479&#x2010;485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9619196</ArticleId><ArticleId IdType="pubmed">35536134</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogliani P, Calzetta L, Coppola A, et&#xa0;al. Are there pulmonary sequelae in patients recovering from COVID&#x2010;19. Respir Res. 2020;21(1):286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598236</ArticleId><ArticleId IdType="pubmed">33126869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Tymoszuk P, Sahanic S, et&#xa0;al. Investigating phenotypes of pulmonary COVID&#x2010;19 recovery: a longitudinal observational prospective multicenter trial. Elife. 2022;11:e72500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8896831</ArticleId><ArticleId IdType="pubmed">35131031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et&#xa0;al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2010;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R, Rahman MM, Rassel MA, et&#xa0;al. Post&#x2010;COVID&#x2010;19 syndrome among symptomatic COVID&#x2010;19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021;16(4):e0249644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a&#x2010;Grimshaw M, Sankowski R, Vald&#xe9;s&#x2010;Ferrer SI. Neurocognitive and psychiatric post&#x2010;coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection. Curr Opin Neurol. 2022;35(3):375&#x2010;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">35283463</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Torres&#x2010;Macho J, Velasco&#x2010;Arribas M, et&#xa0;al. Similar prevalence of long&#x2010;term post&#x2010;COVID symptoms in patients with asthma: a case&#x2013;control study. J Infect. 2021;83(2):237&#x2010;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8089027</ArticleId><ArticleId IdType="pubmed">33957161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y, et&#xa0;al. Symptoms and health outcomes among survivors of COVID&#x2010;19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw Open. 2021;4(9):e2127403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324(6):603&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Palacios&#x2010;Ce&#xf1;a D, G&#xf3;mez&#x2010;Mayordomo V, et&#xa0;al. Long&#x2010;term post&#x2010;COVID symptoms and associated risk factors in previously hospitalized patients: a multicenter study. J Infect. 2021;83(2):237&#x2010;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110627</ArticleId><ArticleId IdType="pubmed">33984399</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, et&#xa0;al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID&#x2010;19. Clin Exp Allergy. 2021;51(9):1107&#x2010;1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia&#x2010;Azorin D, Layos&#x2010;Romero A, Porta&#x2010;Etessam J, et&#xa0;al. Post&#x2010;COVID&#x2010;19 persistent headache: a multicentric 9&#x2010;months follow&#x2010;up study of 905 patients. Cephalalgia. 2022;42(8):804&#x2010;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">35166156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, G&#xf3;mez&#x2010;Mayordomo V, Cuadrado ML, et&#xa0;al. The presence of headache at onset in SARS&#x2010;CoV&#x2010;2 infection is associated with long&#x2010;term post&#x2010;COVID headache and fatigue: a case&#x2013;control study. Cephalalgia. 2021;41(13):1332&#x2010;1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8212025</ArticleId><ArticleId IdType="pubmed">34134526</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Girolamo FG, Fiotti N, Sisto UG, et&#xa0;al. Skeletal muscle in hypoxia and inflammation: insights on the COVID&#x2010;19 pandemic. Front Nutr. 2022;9:865402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9072827</ArticleId><ArticleId IdType="pubmed">35529457</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu Y, Zhang Y, Li Y, et&#xa0;al. Post&#x2010;traumatic stress symptoms in COVID&#x2010;19 survivors: a self&#x2010;report and brain imaging follow&#x2010;up study. Mol Psychiatry. 2021;26(12):7475&#x2010;7480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8290134</ArticleId><ArticleId IdType="pubmed">34285348</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, et&#xa0;al. Persistent psychopathology and neurocognitive impairment in COVID&#x2010;19 survivors: effect of inflammatory biomarkers at three&#x2010;month follow&#x2010;up. Brain Behav Immun. 2021;94:138&#x2010;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmassi C, Cordone A, Bertelloni CA, et&#xa0;al. A longitudinal study of post&#x2010;traumatic stress, depressive, and anxiety symptoms trajectories in subjects with bipolar disorder during the COVID&#x2010;19 pandemic. Eur Psychiatry. 2022;65(1):e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8853854</ArticleId><ArticleId IdType="pubmed">35022099</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, et&#xa0;al. Anxiety and depression in COVID&#x2010;19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2010;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou TM, Joca S, Wegener G, Bay&#x2010;Richter C. Psychiatric and neuropsychiatric sequelae of COVID&#x2010;19&#x2014;a systematic review. Brain Behav Immun. 2021;97:328&#x2010;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn&#xfa;sd&#xf3;ttir I, Lovik A, Unnarsd&#xf3;ttir AB, et&#xa0;al. Acute COVID&#x2010;19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study. Lancet Public Health. 2022;7(5):e406&#x2010;e416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8920517</ArticleId><ArticleId IdType="pubmed">35298894</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda J, Oriol I, Mart&#xed;n M, et&#xa0;al. Long&#x2010;term impact of COVID&#x2010;19 associated acute respiratory distress syndrome. J Infect. 2021;83(5):581&#x2010;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363182</ArticleId><ArticleId IdType="pubmed">34400219</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R, Balanz&#xe1;&#x2010;Mart&#xed;nez V, Luperdi SC, et&#xa0;al. Short&#x2010;term neuropsychiatric outcomes and quality of life in COVID&#x2010;19 survivors. J Intern Med. 2021;290(3):621&#x2010;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, et&#xa0;al. Neurological outcomes 1 year after COVID&#x2010;19 diagnosis: a prospective longitudinal cohort study. Eur J Neurol. 2022;29(6):1685&#x2010;1696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti S, Palladini M, Mazza MG, et&#xa0;al. Long&#x2010;term consequences of COVID&#x2010;19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci. 2022;272(5):773&#x2010;782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546751</ArticleId><ArticleId IdType="pubmed">34698871</ArticleId></ArticleIdList></Reference><Reference><Citation>Dressing A, Bormann T, Blazhenets G, et&#xa0;al. Neuropsychologic profiles and cerebral glucose metabolism in neurocognitive long COVID syndrome. J Nucl Med. 2022;63(7):1058&#x2010;1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9258569</ArticleId><ArticleId IdType="pubmed">34649946</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Simr&#xe9;n J, Ed&#xe9;n A, et&#xa0;al. Neurochemical signs of astrocytic and neuronal injury in acute COVID&#x2010;19 normalizes during long&#x2010;term follow&#x2010;up. EBioMedicine. 2021;70:103512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et&#xa0;al. Neuropathology of patients with COVID&#x2010;19 in Germany: a post&#x2010;mortem case series. Lancet Neurol. 2020;19(11):919&#x2010;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YH, Jiang D, Huang JT. SARS&#x2010;CoV&#x2010;2 detected in cerebrospinal fluid by PCR in a case of COVID&#x2010;19 encephalitis. Brain Behav Immun. 2020;87:149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202824</ArticleId><ArticleId IdType="pubmed">32387508</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneman R, Prat A. The blood&#x2013;brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4292164</ArticleId><ArticleId IdType="pubmed">25561720</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Rissmann M, Benavides F, et&#xa0;al. In vitro and in vivo differences in neurovirulence between D614G, delta and omicron BA.1 SARS&#x2010;CoV&#x2010;2 variants. Acta Neuropathol Commun. 2022;10(1):124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9441226</ArticleId><ArticleId IdType="pubmed">36058935</ArticleId></ArticleIdList></Reference><Reference><Citation>Savelieff MG, Feldman EL, Stino AM. Neurological sequela and disruption of neuron&#x2010;glia homeostasis in SARS&#x2010;CoV&#x2010;2 infection. Neurobiol Dis. 2022;168:105715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8963977</ArticleId><ArticleId IdType="pubmed">35364273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Ashton NJ, Andersson LM, et&#xa0;al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID&#x2010;19. Neurology. 2020;95(12):e1754&#x2010;e1759.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Wu J, Chen T, et&#xa0;al. Long&#x2010;term microstructure and cerebral blood flow changes in patients recovered from COVID&#x2010;19 without neurological manifestations. J Clin Invest. 2021;131(8):e147329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Du YY, Zhao W, Zhou XL, et&#xa0;al. Survivors of COVID&#x2010;19 exhibit altered amplitudes of low frequency fluctuation in the brain: a resting&#x2010;state functional magnetic resonance imaging study at 1&#x2010;year follow&#x2010;up. Neural Regen Res. 2022;17(7):1576&#x2010;1581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8771089</ArticleId><ArticleId IdType="pubmed">34916443</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Ballv&#xe9; A, Llaurad&#xf3; A, et&#xa0;al. Headache: a striking prodromal and persistent symptom, predictive of COVID&#x2010;19 clinical evolution. Cephalalgia. 2020;40(13):1410&#x2010;1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L, Albecka A, Mallery DL, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 infects the brain choroid plexus and disrupts the blood&#x2013;CSF barrier in human brain organoids. Cell Stem Cell. 2020;27(6):951&#x2010;961.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CS, Chang CN, Hu CF, et&#xa0;al. Critical pediatric neurological illness associated with COVID&#x2010;19 (Omicron BA.2.3.7 variant) infection in Taiwan: immunological assessment and viral genome analysis in tertiary medical center. Int J Infect Dis. 2022;124:45&#x2010;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9451934</ArticleId><ArticleId IdType="pubmed">36087642</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, B&#xfc;ttiker P, Weissenberger S, et&#xa0;al. Biomedical perspectives of acute and chronic neurological and neuropsychiatric sequelae of COVID&#x2010;19. Curr Neuropharmacol. 2022;20(6):1229&#x2010;1240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9886822</ArticleId><ArticleId IdType="pubmed">34951387</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelton JF, Shastri AJ, Fletez&#x2010;Brant K, Aslibekyan S, Auton A. The UGT2A1/UGT2A2 locus is associated with COVID&#x2010;19&#x2010;related loss of smell or taste. Nat Genet. 2022;54(2):121&#x2010;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">35039640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohla K, Veldhuizen MG, Green T, et&#xa0;al. A follow&#x2010;up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID&#x2010;19 smell loss. Rhinology. 2022. doi:10.4193/Rhin21.415</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11016179</ArticleId><ArticleId IdType="pubmed">35398877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigiani A. Gustatory dysfunctions in COVID&#x2010;19 patients: possible involvement of taste renin&#x2013;angiotensin system (RAS). Eur Arch Otorhinolaryngol. 2020;277(8):2395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239346</ArticleId><ArticleId IdType="pubmed">32435852</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Sudre CH, Steves CJ, Ourselin S, Spector TD. Quantifying additional COVID&#x2010;19 symptoms will save lives. Lancet. 2020;395(10241):e107&#x2010;e108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272184</ArticleId><ArticleId IdType="pubmed">32505221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazhytska M, Kodra A, Hoagland DA, et&#xa0;al. Non&#x2010;cell&#x2010;autonomous disruption of nuclear architecture as a potential cause of COVID&#x2010;19&#x2010;induced anosmia. Cell. 2022;185(6):1052&#x2010;1064.e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8808699</ArticleId><ArticleId IdType="pubmed">35180380</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Wong LR, Li K, et&#xa0;al. COVID&#x2010;19 treatments and pathogenesis including anosmia in K18&#x2010;hACE2 mice. Nature. 2021;589(7843):603&#x2010;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855185</ArticleId><ArticleId IdType="pubmed">33166988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciofalo A, Cavaliere C, Masieri S, et&#xa0;al. Long&#x2010;term subjective and objective assessment of smell and taste in COVID&#x2010;19. Cells. 2022;11(5):788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8909596</ArticleId><ArticleId IdType="pubmed">35269410</ArticleId></ArticleIdList></Reference><Reference><Citation>Xydakis MS, Albers MW, Holbrook EH, et&#xa0;al. Post&#x2010;viral effects of COVID&#x2010;19 in the olfactory system and their implications. Lancet Neurol. 2021;20(9):753&#x2010;761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324113</ArticleId><ArticleId IdType="pubmed">34339626</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo&#x2010;Rizzo P, Hummel T, Hopkins C, et&#xa0;al. High prevalence of long&#x2010;term olfactory, gustatory, and chemesthesis dysfunction in post&#x2010;COVID&#x2010;19 patients: a matched case&#x2013;control study with one&#x2010;year follow&#x2010;up using a comprehensive psychophysical evaluation. Rhinology. 2021;59(6):517&#x2010;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">34553706</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho DH, Reiter ER, French E, Costanzo RM. Decreasing incidence of chemosensory changes by COVID&#x2010;19 variant. Otolaryngol Head Neck Surg. 2022. doi:10.1177/01945998221097656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9630171</ArticleId><ArticleId IdType="pubmed">35503739</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinato G, Fabbris C, Polesel J, et&#xa0;al. Alterations in smell or taste in mildly symptomatic outpatients with SARS&#x2010;CoV&#x2010;2 infection. JAMA. 2020;323(20):2089&#x2010;2090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177631</ArticleId><ArticleId IdType="pubmed">32320008</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Neurological infection with SARS&#x2010;CoV&#x2010;2&#x2014;the story so far. Nat Rev Neurol. 2021;17(2):65&#x2010;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789883</ArticleId><ArticleId IdType="pubmed">33414554</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciarelli V, Nasi M, Bianco F, et&#xa0;al. Depression pandemic and cardiovascular risk in the COVID&#x2010;19 era and long COVID syndrome: gender makes a difference. Trends Cardiovasc Med. 2022;32(1):12&#x2010;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8490128</ArticleId><ArticleId IdType="pubmed">34619336</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Schneider AM, Mehta A, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 viremia is associated with distinct proteomic pathways and predicts COVID&#x2010;19 outcomes. J Clin Invest. 2021;131(13):e148635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245177</ArticleId><ArticleId IdType="pubmed">34196300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez&#x2010;Salazar B, Holwerda M, St&#xfc;dle C, et&#xa0;al. COVID&#x2010;19 and the vasculature: current aspects and long&#x2010;term consequences. Front Cell Dev Biol. 2022;10:824851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8887620</ArticleId><ArticleId IdType="pubmed">35242762</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerotziafas GT, Catalano M, Colgan MP, et&#xa0;al. Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID&#x2010;19: position paper from VAS&#x2010;European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost. 2020;120(12):1597&#x2010;1628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869052</ArticleId><ArticleId IdType="pubmed">32920811</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Wirtheim E, Vetter P, et&#xa0;al. Long&#x2010;term consequences of COVID&#x2010;19: research needs. Lancet Infect Dis. 2020;20(10):1115&#x2010;1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mani NS, Budak JZ, Lan KF, et&#xa0;al. Prevalence of coronavirus disease 2019 infection and outcomes among symptomatic healthcare workers in Seattle, Washington. Clin Infect Dis. 2020;71(10):2702&#x2010;2707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337651</ArticleId><ArticleId IdType="pubmed">32548613</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Cao B. Post&#x2010;acute conditions of patients with COVID&#x2010;19 not requiring hospital admission. Lancet Infect Dis. 2021;21(10):1335&#x2010;1336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110207</ArticleId><ArticleId IdType="pubmed">33984264</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, et&#xa0;al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19(10):2546&#x2010;2553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E, Souvaliotis N, Lampsas S, et&#xa0;al. Endothelial dysfunction in acute and long standing COVID&#x2010;19: a prospective cohort study. Vascul Pharmacol. 2022;144:106975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893931</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId></ArticleIdList></Reference><Reference><Citation>Melkumyants A, Buryachkovskaya L, Lomakin N, Antonova O, Serebruany V. Mild COVID&#x2010;19 and impaired blood cell&#x2010;endothelial crosstalk: considering long&#x2010;term use of antithrombotics. Thromb Haemost. 2022;122(1):123&#x2010;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">34482535</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen LA, Geldhof V, Pasut A, Carmeliet P. COVID&#x2010;19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389&#x2010;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. COVID&#x2010;19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269&#x2010;270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7143200</ArticleId><ArticleId IdType="pubmed">32273594</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Levi M, Hunt BJ. Prevention and management of thrombosis in hospitalised patients with COVID&#x2010;19 pneumonia. Lancet Respir Med. 2022;10(2):214&#x2010;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8616572</ArticleId><ArticleId IdType="pubmed">34838161</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K, Gronski PA, Kiyan Y, et&#xa0;al. Injury to the endothelial glycocalyx in critically ill patients with COVID&#x2010;19. Am J Respir Crit Care Med. 2020;202(8):1178&#x2010;1181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7560808</ArticleId><ArticleId IdType="pubmed">32833500</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya JM, Rojas M, Salinas ML, et&#xa0;al. Post&#x2010;COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021;20(11):102947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Navarro&#x2010;Santana M, Plaza&#x2010;Manzano G, Palacios&#x2010;Ce&#xf1;a D, Arendt&#x2010;Nielsen L. Time course prevalence of post&#x2010;COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta&#x2010;analysis. Pain. 2022;163(7):1220&#x2010;1231.</Citation><ArticleIdList><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe9;rard M, Mahmutovic M, Malgras A, et&#xa0;al. Long&#x2010;term evolution of malnutrition and loss of muscle strength after COVID&#x2010;19: a major and neglected component of long COVID&#x2010;19. Nutrients. 2021;13(11):3964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8618979</ArticleId><ArticleId IdType="pubmed">34836219</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto OH, Mera RM, P&#xe9;rez P, Recalde BY, Costa AF, Sedler MJ. Hand grip strength before and after SARS&#x2010;CoV&#x2010;2 infection in community&#x2010;dwelling older adults. J Am Geriatr Soc. 2021;69(10):2722&#x2010;2731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447376</ArticleId><ArticleId IdType="pubmed">34124775</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Rodr&#xed;guez&#x2010;Jim&#xe9;nez J, Fuensalida&#x2010;Novo S, et&#xa0;al. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long&#x2010;term post&#x2010;COVID sequelae: a case&#x2013;control study. Pain. 2021;162(12):2832&#x2010;2840.</Citation><ArticleIdList><ArticleId IdType="pubmed">33863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, de&#x2010;la&#x2010;Llave&#x2010;Rinc&#xf3;n AI, Ortega&#x2010;Santiago R, et&#xa0;al. Prevalence and risk factors of musculoskeletal pain symptoms as long&#x2010;term post&#x2010;COVID sequelae in hospitalized COVID&#x2010;19 survivors: a multicenter study. Pain. 2022;163(9):e989&#x2010;e996.</Citation><ArticleIdList><ArticleId IdType="pubmed">34913880</ArticleId></ArticleIdList></Reference><Reference><Citation>Disser NP, De Micheli AJ, Schonk MM, et&#xa0;al. Musculoskeletal consequences of COVID&#x2010;19. J Bone Joint Surg Am. 2020;102(14):1197&#x2010;1204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7508274</ArticleId><ArticleId IdType="pubmed">32675661</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares MN, Eggelbusch M, Naddaf E, et&#xa0;al. Skeletal muscle alterations in patients with acute Covid&#x2010;19 and post&#x2010;acute sequelae of Covid&#x2010;19. J Cachexia Sarcopenia Muscle. 2022;13(1):11&#x2010;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8818659</ArticleId><ArticleId IdType="pubmed">34997689</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowicz K, G&#x105;sowski J, Michel JP, Veronese N. Post&#x2010;COVID&#x2010;19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021;33(10):2887&#x2010;2898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8323089</ArticleId><ArticleId IdType="pubmed">34328636</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto K, Takeshita H, Rakugi H. ACE2, angiotensin 1&#x2013;7 and skeletal muscle: review in the era of COVID&#x2010;19. Clin Sci. 2020;134(22):3047&#x2010;3062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687025</ArticleId><ArticleId IdType="pubmed">33231620</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavario P, De Marzo V, Lotti R, et&#xa0;al. Cardiopulmonary exercise testing in COVID&#x2010;19 patients at 3 months follow&#x2010;up. Int J Cardiol. 2021;340:113&#x2010;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8302817</ArticleId><ArticleId IdType="pubmed">34311011</ArticleId></ArticleIdList></Reference><Reference><Citation>Standl E, Schnell O. Heart failure outcomes and Covid&#x2010;19. Diabetes Res Clin Pract. 2021;175:108794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8020602</ArticleId><ArticleId IdType="pubmed">33831494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindermann I, Barth C, Mahfoud F, et&#xa0;al. Update on myocarditis. J Am Coll Cardiol. 2012;59(9):779&#x2010;792.</Citation><ArticleIdList><ArticleId IdType="pubmed">22361396</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz NR, Jethani N, Chen J, et&#xa0;al. Myocardial injury in adults hospitalized with COVID&#x2010;19. Circulation. 2020;142(24):2393&#x2010;2395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736200</ArticleId><ArticleId IdType="pubmed">33151762</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et&#xa0;al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID&#x2010;19). JAMA Cardiol. 2020;5(11):1265&#x2010;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggers KM, Jernberg T, Lindahl B. Cardiac troponin elevation in patients without a specific diagnosis. J Am Coll Cardiol. 2019;73(1):1&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30621937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan MS, Bertolino L, Zampino R, Durante&#x2010;Mangoni E. Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review. Clin Microbiol Infect. 2021;27(9):1250&#x2010;1261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="pubmed">34171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber B, Siddiqi H, Zhou G, et&#xa0;al. Relationship between myocardial injury during index hospitalization for SARS&#x2010;CoV&#x2010;2 infection and longer&#x2010;term outcomes. J Am Heart Assoc. 2022;11(1):e022010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9075193</ArticleId><ArticleId IdType="pubmed">34970914</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulson N, Petek BJ, Drezner JA, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 cardiac involvement in young competitive athletes. Circulation. 2021;144(4):256&#x2010;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8300154</ArticleId><ArticleId IdType="pubmed">33866822</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez MW, Tucker AM, Bloom OJ, et&#xa0;al. Prevalence of inflammatory heart disease among professional athletes with prior COVID&#x2010;19 infection who received systematic return&#x2010;to&#x2010;play cardiac screening. JAMA Cardiol. 2021;6(7):745&#x2010;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934073</ArticleId><ArticleId IdType="pubmed">33662103</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels CJ, Rajpal S, Greenshields JT, et&#xa0;al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS&#x2010;CoV&#x2010;2 infection: results from the big ten COVID&#x2010;19 cardiac registry. JAMA Cardiol. 2021;6(9):1078&#x2010;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D, Wagner J, Shumliakivska M, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc Res. 2020;116(14):2207&#x2010;2215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543363</ArticleId><ArticleId IdType="pubmed">32966582</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, Wu H, Tan Y, Li M, Yang D, Li S. Mechanisms and treatments of myocardial injury in patients with corona virus disease 2019. Life Sci. 2020;262:118496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518803</ArticleId><ArticleId IdType="pubmed">32987060</ArticleId></ArticleIdList></Reference><Reference><Citation>Chidambaram V, Kumar A, Calcaterra G, Mehta JL. Persistent cardiac injury&#x2014;an important component of long COVID&#x2010;19 syndrome. EBioMedicine. 2022;77:103892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8864184</ArticleId><ArticleId IdType="pubmed">35219086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, et&#xa0;al. Postacute COVID&#x2010;19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163(2):495&#x2010;506.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Settanni CR, Ianiro G, Ponziani FR, et&#xa0;al. COVID&#x2010;19 as a trigger of irritable bowel syndrome: a review of potential mechanisms. World J Gastroenterol. 2021;27(43):7433&#x2010;7445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613742</ArticleId><ArticleId IdType="pubmed">34887641</ArticleId></ArticleIdList></Reference><Reference><Citation>Sica R, Pennoni S, Penta L, Riccioni S, Di Cara G, Verrotti A. Gastrointestinal and hepatic involvement during COVID&#x2010;19 pandemic: a focus on pediatric population and possible future implications. World J Gastroenterol. 2021;27(40):7000&#x2010;7004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8567473</ArticleId><ArticleId IdType="pubmed">34790020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Zhao N, Shu Y, Han S, Chen B, Shu X. Effect of gastrointestinal symptoms in patients with COVID&#x2010;19. Gastroenterology. 2020;158(8):2294&#x2010;2297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270807</ArticleId><ArticleId IdType="pubmed">32199880</ArticleId></ArticleIdList></Reference><Reference><Citation>Livanos AE, Jha D, Cossarini F, et&#xa0;al. Intestinal host response to SARS&#x2010;CoV&#x2010;2 infection and COVID&#x2010;19 outcomes in patients with gastrointestinal symptoms. Gastroenterology. 2021;160(7):2435&#x2010;2450.e34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7931673</ArticleId><ArticleId IdType="pubmed">33676971</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharbi KS, Singh Y, Hassan Almalki W, et&#xa0;al. Gut microbiota disruption in COVID&#x2010;19 or post&#x2010;COVID illness association with severity biomarkers: a possible role of pre/pro&#x2010;biotics in manipulating microflora. Chem Biol Interact. 2022;358:109898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8934739</ArticleId><ArticleId IdType="pubmed">35331679</ArticleId></ArticleIdList></Reference><Reference><Citation>Marasco G, Cremon C, Barbaro MR, et&#xa0;al. Prevalence of gastrointestinal symptoms in severe acute respiratory syndrome coronavirus 2 infection: results of the prospective controlled multinational GI&#x2010;COVID&#x2010;19 study. Am J Gastroenterol. 2022;117(1):147&#x2010;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10337314</ArticleId><ArticleId IdType="pubmed">34751672</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Zhang T, Xue K, et&#xa0;al. Fecal multi&#x2010;omics analysis reveals diverse molecular alterations of gut ecosystem in COVID&#x2010;19 patients. Anal Chim Acta. 2021;1180:338881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310733</ArticleId><ArticleId IdType="pubmed">34538334</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak J, Su Q, et&#xa0;al. Gut microbiota dynamics in a prospective cohort of patients with post&#x2010;acute COVID&#x2010;19 syndrome. Gut. 2022;71(3):544&#x2010;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Gu S, Chen Y, et&#xa0;al. Six&#x2010;month follow&#x2010;up of gut microbiota richness in patients with COVID&#x2010;19. Gut. 2022;71(1):222&#x2010;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataf S, Pays L. Molecular insights into SARS&#x2010;CoV2&#x2010;induced alterations of the gut/brain axis. Int J Mol Sci. 2021;22(19):10440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8508788</ArticleId><ArticleId IdType="pubmed">34638785</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto T, Perlot T, Rehman A, et&#xa0;al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477&#x2010;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095315</ArticleId><ArticleId IdType="pubmed">22837003</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestad B, Ueland T, Lerum TV, et&#xa0;al. Respiratory dysfunction three months after severe COVID&#x2010;19 is associated with gut microbiota alterations. J Intern Med. 2022;291(6):801&#x2010;812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115297</ArticleId><ArticleId IdType="pubmed">35212063</ArticleId></ArticleIdList></Reference><Reference><Citation>Redd WD, Zhou JC, Hathorn KE, et&#xa0;al. Prevalence and characteristics of gastrointestinal symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection in the United States: a multicenter cohort study. Gastroenterology. 2020;159(2):765&#x2010;767.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195377</ArticleId><ArticleId IdType="pubmed">32333911</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et&#xa0;al. Immunological dysfunction persists for 8 months following initial mild&#x2010;to&#x2010;moderate SARS&#x2010;CoV&#x2010;2 infection. Nat Immunol. 2022;23(2):210&#x2010;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, et&#xa0;al. Long&#x2010;term perturbation of the peripheral immune system months after SARS&#x2010;CoV&#x2010;2 infection. BMC Med. 2022;20(1):26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta&#x2010;Ampudia Y, Monsalve DM, Rojas M, et&#xa0;al. Persistent autoimmune activation and proinflammatory state in post&#x2010;coronavirus disease 2019 syndrome. J Infect Dis. 2022;225(12):2155&#x2010;2162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Yang X, Wang H, et&#xa0;al. Analysis of the long&#x2010;term impact on cellular immunity in COVID&#x2010;19&#x2010;recovered individuals reveals a profound NKT cell impairment. mBio. 2021;12(2):e00085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8092197</ArticleId><ArticleId IdType="pubmed">33906918</ArticleId></ArticleIdList></Reference><Reference><Citation>Starshinova AA, Kudryavtsev I, Malkova A, et&#xa0;al. Molecular and cellular mechanisms of M. tuberculosis and SARS&#x2010;CoV&#x2010;2 infections&#x2010;unexpected similarities of pathogenesis and what to expect from co&#x2010;infection. Int J Mol Sci. 2022;23(4):2235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8878934</ArticleId><ArticleId IdType="pubmed">35216349</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortellini A, Gennari A, Pommeret F, et&#xa0;al. COVID&#x2010;19 sequelae and the host proinflammatory response: an analysis from the OnCovid Registry. J Natl Cancer Inst. 2022;114(7):979&#x2010;987.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047221</ArticleId><ArticleId IdType="pubmed">35417006</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L, Chaudhary K, Saha A, et&#xa0;al. AKI in hospitalized patients with COVID&#x2010;19. J Am Soc Nephrol. 2021;32(1):151&#x2010;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894657</ArticleId><ArticleId IdType="pubmed">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, et&#xa0;al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708&#x2010;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Farkash EA, Wilson AM, Jentzen JM. Ultrastructural evidence for direct renal infection with SARS&#x2010;CoV&#x2010;2. J Am Soc Nephrol. 2020;31(8):1683&#x2010;1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7460898</ArticleId><ArticleId IdType="pubmed">32371536</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#x142;owacka M, Lipka S, M&#x142;ynarska E, Franczyk B, Rysz J. Acute kidney injury in COVID&#x2010;19. Int J Mol Sci. 2021;22(15):8081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8347536</ArticleId><ArticleId IdType="pubmed">34360866</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent J, Aklilu A, Yamamoto Y, et&#xa0;al. Assessment of acute kidney injury and longitudinal kidney function after hospital discharge among patients with and without COVID&#x2010;19. JAMA Netw Open. 2021;4(3):e211095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948062</ArticleId><ArticleId IdType="pubmed">33688965</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel E, Sekulic M, Kudose S, et&#xa0;al. Kidney allograft biopsy findings after COVID&#x2010;19. Am J Transplant. 2021;21(12):4032&#x2010;4042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441660</ArticleId><ArticleId IdType="pubmed">34403563</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et&#xa0;al. 6&#x2010;Month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Tan X, Luo P, et&#xa0;al. Changes in glomerular filtration rate and metabolomic differences in severely ill coronavirus disease survivors 3 months after discharge. Biochim Biophys Acta Mol Basis Dis. 2022;1868(1):166289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516480</ArticleId><ArticleId IdType="pubmed">34656797</ArticleId></ArticleIdList></Reference><Reference><Citation>Akilesh S, Nast CC, Yamashita M, et&#xa0;al. Multicenter clinicopathologic correlation of kidney biopsies performed in COVID&#x2010;19 patients presenting with acute kidney injury or proteinuria. Am J Kidney Dis. 2021;77(1):82&#x2010;93.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546949</ArticleId><ArticleId IdType="pubmed">33045255</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Reis T. Kidney involvement in COVID&#x2010;19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020;16(6):308&#x2010;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144544</ArticleId><ArticleId IdType="pubmed">32273593</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen J, Reimer KC, Nagai JS, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2022;29(2):217&#x2010;231.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8709832</ArticleId><ArticleId IdType="pubmed">35032430</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu S, Liu H, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 infection of the liver directly contributes to hepatic impairment in patients with COVID&#x2010;19. J Hepatol. 2020;73(4):807&#x2010;816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211738</ArticleId><ArticleId IdType="pubmed">32437830</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth NC, Kim A, Vitkovski T, et&#xa0;al. Post&#x2010;COVID&#x2010;19 cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116(5):1077&#x2010;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Herta T, Berg T. COVID&#x2010;19 and the liver&#x2014;lessons learned. Liver Int. 2021;41(suppl 1):1&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447354</ArticleId><ArticleId IdType="pubmed">34155789</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao R, Qiu Y, He JS, et&#xa0;al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667&#x2010;678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217643</ArticleId><ArticleId IdType="pubmed">32405603</ArticleId></ArticleIdList></Reference><Reference><Citation>Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID&#x2010;19 and the liver: a 2021 update. Liver Int. 2021;41(9):1988&#x2010;1998.</Citation><ArticleIdList><ArticleId IdType="pubmed">34152690</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et&#xa0;al. Multiorgan impairment in low&#x2010;risk individuals with post&#x2010;COVID&#x2010;19 syndrome: a prospective, community&#x2010;based study. BMJ Open. 2021;11(3):e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip TC, Lui GC, Wong VW, et&#xa0;al. Liver injury is independently associated with adverse clinical outcomes in patients with COVID&#x2010;19. Gut. 2021;70(4):733&#x2010;742.</Citation><ArticleIdList><ArticleId IdType="pubmed">32641471</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo KY, Invernizzi A, Staurenghi G, Cheung C. COVID&#x2010;19&#x2010;related retinal micro&#x2010;vasculopathy&#x2014;a review of current evidence. Am J Ophthalmol. 2022;235:98&#x2010;110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8465265</ArticleId><ArticleId IdType="pubmed">34587494</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilbao&#x2010;Malav&#xe9; V, Gonz&#xe1;lez&#x2010;Zamora J, Saenz de Viteri M, et&#xa0;al. Persistent retinal microvascular impairment in COVID&#x2010;19 bilateral pneumonia at 6&#x2010;months follow&#x2010;up assessed by optical coherence tomography angiography. Biomedicines. 2021;9(5):502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8147391</ArticleId><ArticleId IdType="pubmed">34063291</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F, Xiao X, Guo J, et&#xa0;al. No evidence of severe acute respiratory syndrome&#x2010;coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril. 2020;113(6):1135&#x2010;1139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164916</ArticleId><ArticleId IdType="pubmed">32482249</ArticleId></ArticleIdList></Reference><Reference><Citation>Donders G, Bosmans E, Reumers J, et&#xa0;al. Sperm quality and absence of SARS&#x2010;CoV&#x2010;2 RNA in semen after COVID&#x2010;19 infection: a prospective, observational study and validation of the sperm COVID test. Fertil Steril. 2022;117(2):287&#x2010;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8685303</ArticleId><ArticleId IdType="pubmed">34937665</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et&#xa0;al. Symptoms and risk factors for long COVID in non&#x2010;hospitalized adults. Nat Med. 2022;28(8):1706&#x2010;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Wang H, Tian L, et&#xa0;al. COVID&#x2010;19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther. 2022;7(1):146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9062866</ArticleId><ArticleId IdType="pubmed">35504917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziqi W, Kai C, Costabel U, Xiaoju Z. Nanotechnology&#x2010;facilitated vaccine development during the coronavirus disease 2019 (COVID&#x2010;19) pandemic. Exploration. 2022. doi:10.1002/EXP.20210082</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349967</ArticleId><ArticleId IdType="pubmed">35941992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Do vaccines protect against long COVID? What the data say. Nature. 2021;599(7886):546&#x2010;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">34815580</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et&#xa0;al. Risk factors and disease profile of post&#x2010;vaccination SARS&#x2010;CoV&#x2010;2 infection in UK users of the COVID symptom study app: a prospective, community&#x2010;based, nested, case&#x2013;control study. Lancet Infect Dis. 2022;22(1):43&#x2010;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, et&#xa0;al. Trajectory of long covid symptoms after Covid&#x2010;19 vaccination: community based cohort study. BMJ. 2022;377:e069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Milne A, Samms E, Stadon L, Maskell NA, Hamilton FW. Symptoms after COVID&#x2010;19 vaccination in patients with persistent symptoms after acute infection: a case series. Ann Intern Med. 2021;174(9):1334&#x2010;1336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8252827</ArticleId><ArticleId IdType="pubmed">34029484</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS&#x2010;CoV&#x2010;2 infection. Nat Med. 2022;28(7):1461&#x2010;1467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six&#x2010;month sequelae of post&#x2010;vaccination SARS&#x2010;CoV&#x2010;2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 2022;103:154&#x2010;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S, Tsuzuki S, Suzuki M, et&#xa0;al. Post COVID&#x2010;19 condition of the omicron variant of SARS&#x2010;CoV&#x2010;2. J Infect Chemother. 2022;28(11):1546&#x2010;1551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Polidori L, et&#xa0;al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS&#x2010;CoV&#x2010;2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618&#x2010;1624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandal LT, MacDonald E, Veneti L, et&#xa0;al. Outbreak caused by the SARS&#x2010;CoV&#x2010;2 omicron variant in Norway, November to December 2021. Euro Surveill. 2021;26(50):2101147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728491</ArticleId><ArticleId IdType="pubmed">34915975</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R, Bili&#x144;ska K, von Bartheld C. Why does the omicron variant largely spare olfactory function? Implications for the pathogenesis of anosmia in COVID&#x2010;19. J Infect Dis. 2022;226(8):1304&#x2010;1308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9129133</ArticleId><ArticleId IdType="pubmed">35467743</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo&#x2010;Rizzo P, Tirelli G, Meloni P, et&#xa0;al. Coronavirus disease 2019 (COVID&#x2010;19)&#x2010;related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome&#x2010;coronavirus&#x2010;2 (SARS&#x2010;CoV&#x2010;2) Omicron variant. Int Forum Allergy Rhinol. 2022;12(10):1273&#x2010;1281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9082058</ArticleId><ArticleId IdType="pubmed">35286777</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Pekosz A, Villano JS, et&#xa0;al. Evolution of nasal and olfactory infection characteristics of SARS&#x2010;CoV&#x2010;2 variants. bioRxiv. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11014658</ArticleId><ArticleId IdType="pubmed">38483537</ArticleId></ArticleIdList></Reference><Reference><Citation>Seehusen F, Clark JJ, Sharma P, et&#xa0;al. Neuroinvasion and neurotropism by SARS&#x2010;CoV&#x2010;2 variants in the K18&#x2010;hACE2 mouse. Viruses. 2022;14(5):1020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9146514</ArticleId><ArticleId IdType="pubmed">35632761</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, et&#xa0;al. Neurological and psychiatric risk trajectories after SARS&#x2010;CoV&#x2010;2 infection: an analysis of 2&#x2010;year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. Lancet Psychiatry. 2022;9(10):815&#x2010;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H, Lin H, Mai Y, Liu H, Chen W. Clinical features and predictive factors related to liver injury in SARS&#x2010;CoV&#x2010;2 delta and omicron variant&#x2010;infected patients. Eur J Gastroenterol Hepatol. 2022;34(9):933&#x2010;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">35482929</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2010;de&#x2010;Las&#x2010;Pe&#xf1;as C, Cancela&#x2010;Cilleruelo I, Rodr&#xed;guez&#x2010;Jim&#xe9;nez J, et&#xa0;al. Associated&#x2010;onset symptoms and post&#x2010;COVID&#x2010;19 symptoms in hospitalized COVID&#x2010;19 survivors infected with Wuhan, alpha or delta SARS&#x2010;CoV&#x2010;2 variant. Pathogens. 2022;11(7):725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9320021</ArticleId><ArticleId IdType="pubmed">35889971</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in South Africa during the COVID&#x2010;19 omicron wave compared with previous waves. JAMA. 2022;327(6):583&#x2010;584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719272</ArticleId><ArticleId IdType="pubmed">34967859</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS&#x2010;CoV&#x2010;2. Lancet. 2022;399(10343):2263&#x2010;2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, et&#xa0;al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11(1):16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, Moik F, Klok FA, et&#xa0;al. Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration. 2022;101(6):593&#x2010;601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan Ii RB, Hogan Iii RB, Cannon T, et&#xa0;al. Dual&#x2010;histamine receptor blockade with cetirizine&#x2014;famotidine reduces pulmonary symptoms in COVID&#x2010;19 patients. Pulm Pharmacol Ther. 2020;63:101942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455799</ArticleId><ArticleId IdType="pubmed">32871242</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS&#x2010;CoV&#x2010;2 &#x2018;long&#x2010;haulers&#x2019;. Chronic Dis Transl Med. 2021;7(1):14&#x2010;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S, Nojima J, Kajimoto O, et&#xa0;al. Ubiquinol&#x2010;10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome. Biofactors. 2016;42(4):431&#x2010;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">27125909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang L, Gong J. Mitochondrial&#x2010;targeted ubiquinone: a potential treatment for COVID&#x2010;19. Med Hypotheses. 2020;144:110161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403158</ArticleId><ArticleId IdType="pubmed">32795832</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossato MS, Brilli E, Ferri N, Giordano G, Tarantino G. Observational study on the benefit of a nutritional supplement, supporting immune function and energy metabolism, on chronic fatigue associated with the SARS&#x2010;CoV&#x2010;2 post&#x2010;infection progress. Clin Nutr ESPEN. 2021;46:510&#x2010;518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420132</ArticleId><ArticleId IdType="pubmed">34857243</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazzolla AP, Lovero R, Lo Muzio L, et&#xa0;al. Taste and smell disorders in COVID&#x2010;19 patients: role of interleukin&#x2010;6. ACS Chem Neurosci. 2020;11(17):2774&#x2010;2781.</Citation><ArticleIdList><ArticleId IdType="pubmed">32786309</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. COVID and smell loss: answers begin to emerge. Nature. 2022;606(7915):631&#x2010;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">35681006</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Hopkins C, Petrocelli M, et&#xa0;al. Smell and taste recovery in coronavirus disease 2019 patients: a 60&#x2010;day objective and prospective study. J Laryngol Otol. 2020;134(8):703&#x2010;709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471571</ArticleId><ArticleId IdType="pubmed">32782030</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce M, Agostoni P, B&#xf8;tker HE, et&#xa0;al. COVID&#x2010;19&#x2010;related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res. 2021;117(10):2148&#x2010;2160.</Citation><ArticleIdList><ArticleId IdType="pubmed">34117887</ArticleId></ArticleIdList></Reference><Reference><Citation>Advani R, Str&#xf8;msnes TA, Stjernstr&#xf8;m E, Lugg ST. Multiple simultaneous embolic cerebral infarctions 11 months after COVID&#x2010;19. Thromb J. 2021;19(1):57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8371419</ArticleId><ArticleId IdType="pubmed">34407847</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar MM, Shin JJ, Kang I, Landry M. Diagnosis of SARS&#x2010;CoV&#x2010;2 infection in the setting of the cytokine release syndrome. Expert Rev Mol Diagn. 2020;20(11):1087&#x2010;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">32990479</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Fogarty H, Dyer A, et&#xa0;al. Prolonged elevation of D&#x2010;dimer levels in convalescent COVID&#x2010;19 patients is independent of the acute phase response. J Thromb Haemost. 2021;19(4):1064&#x2010;1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Flumignan RL, Tin&#xf4;co J, Pascoal PI, et&#xa0;al. Prophylactic anticoagulants for people hospitalised with COVID&#x2010;19. Cochrane Database Syst Rev. 2020;10(10):CD013739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8166900</ArticleId><ArticleId IdType="pubmed">33502773</ArticleId></ArticleIdList></Reference><Reference><Citation>Salisbury R, Iotchkova V, Jaafar S, et&#xa0;al. Incidence of symptomatic, image&#x2010;confirmed venous thromboembolism following hospitalization for COVID&#x2010;19 with 90&#x2010;day follow&#x2010;up. Blood Adv. 2020;4(24):6230&#x2010;6239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7757009</ArticleId><ArticleId IdType="pubmed">33351117</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams B, Mancia G, Spiering W, et&#xa0;al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021&#x2010;3104.</Citation><ArticleIdList><ArticleId IdType="pubmed">30165516</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, et&#xa0;al. COVID&#x2010;19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. 2021;19(3):345&#x2010;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">32921216</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long&#x2010;term implications of COVID&#x2010;19. Nat Rev Cardiol. 2022;19(5):332&#x2010;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8532434</ArticleId><ArticleId IdType="pubmed">34686843</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight MA, Court C, Buxton M, Husain L. Management of post&#x2010;acute Covid&#x2010;19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SK, Guevarra RB, Kim YT, et&#xa0;al. Role of probiotics in human gut microbiome&#x2010;associated diseases. J Microbiol Biotechnol. 2019;29(9):1335&#x2010;1340.</Citation><ArticleIdList><ArticleId IdType="pubmed">31434172</ArticleId></ArticleIdList></Reference><Reference><Citation>Xavier&#x2010;Santos D, Padilha M, Fabiano GA, et&#xa0;al. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID&#x2010;19: a bibliometric analysis and systematic review. Trends Food Sci Technol. 2022;120:174&#x2010;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8720301</ArticleId><ArticleId IdType="pubmed">35002079</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Ye Q. Kidney involvement in COVID&#x2010;19 and its treatments. J Med Virol. 2021;93(3):1387&#x2010;1395.</Citation><ArticleIdList><ArticleId IdType="pubmed">33150973</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamid S, Alvares da Silva MR, Burak KW, et&#xa0;al. WGO guidance for the care of patients with COVID&#x2010;19 and liver disease. J Clin Gastroenterol. 2021;55(1):1&#x2010;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7713641</ArticleId><ArticleId IdType="pubmed">33230011</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Liu S. Proposed subtypes of post&#x2010;COVID&#x2010;19 syndrome (or long&#x2010;COVID) and their respective potential therapies. Rev Med Virol. 2022;32(4):e2315.</Citation><ArticleIdList><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients. 2021;13(4):1154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannos P, Prokopidis K. Gut dysbiosis and long COVID&#x2010;19: feeling gutted. J Med Virol. 2022;94(7):2917&#x2010;2918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088471</ArticleId><ArticleId IdType="pubmed">35233795</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, et&#xa0;al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN&#x2010;EndCOV study. Front Cardiovasc Med. 2021;8:745758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, et&#xa0;al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID&#x2010;19 in 2020 and 2021. JAMA. 2022;328(16):1604&#x2010;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long&#x2010;haul COVID. Nat Immunol. 2022;23(2):194&#x2010;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et&#xa0;al. Physical, cognitive, and mental health impacts of COVID&#x2010;19 after hospitalisation (PHOSP&#x2010;COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275&#x2010;1287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Ming C, Cen Y, et&#xa0;al. Post&#x2010;sequelae one year after hospital discharge among older COVID&#x2010;19 patients: a multi&#x2010;center prospective cohort study. J Infect. 2022;84(2):179&#x2010;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662958</ArticleId><ArticleId IdType="pubmed">34902448</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, et&#xa0;al. Physical and mental health 3 months after SARS&#x2010;CoV&#x2010;2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022;6(4):230&#x2010;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>